Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Interferon alpha (IFN-ɑ) among Human Immunodeficiency Virus (HIV) patients exposed to Plasmodium falciparum infection in selected Hospitals in Niger State, Nigeria

Breadcrumb

  • Home
  • Interferon alpha (IFN-ɑ) among Human Immunodeficiency Virus (HIV) patients exposed to Plasmodium falciparum infection in selected Hospitals in Niger State, Nigeria

Muhammad TH *, Inabo HI, Machido DA and Ameh JB

Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Nigeria.

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2023, 13(03), 026–032.
Article DOI: 10.30574/wjbphs.2023.13.3.0094
DOI url: https://doi.org/10.30574/wjbphs.2023.13.3.0094

Received on 25 January 2023; revised on 02 March 2023; accepted on 06 March 2023

Both Human Immunodeficiency Virus (HIV) and Plasmodium falciparum (P. falciparum) infection are associated with production of several cytokines such as type I Interferons which may be beneficial to the host during acute infection. The plasma level of type I interferons could vary among HIV patients co-infected with P. falciparum. This study therefore, aims to quantify the level of IFN-α, a type 1 interferon, among HIV patients exposed to P. falciparum infection in selected Hospitals in Niger State, Nigeria. This was a cross-sectional study. Blood samples were collected from 300 HIV patients for blood film microscopy using Giemsa staining technique and CD4 count using flow cytometer. Of these, 65 were selected for IFN-α analysis (22 controls and 43 HIV/P. falciparum patients) determined using enzyme-linked immunosorbent assay (ELISA). (Chi-square test, P < 0.05). Higher levels of IFN-α were observed in patients with mild P. falciparum infection and in those with low CD4 below 200 cells/µL. Conclusively, mild P. falciparum infection in HIV patients is characterized by up-regulated IFN-α activity.

Plasmodium falciparum; IFN-α; HIV; Malaria; CD4

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2023-0094.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Muhammad TH, Inabo HI, Machido DA and Ameh JB. Interferon alpha (IFN-ɑ) among Human Immunodeficiency Virus (HIV) patients exposed to Plasmodium falciparum infection in selected Hospitals in Niger State, Nigeria. World Journal of Biology Pharmacy and Health Sciences, 2023, 13(03), 026–032. Article DOI: https://doi.org/10.30574/wjbphs.2023.13.3.0094

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution